| Literature DB >> 27836184 |
Miyuki Morikawa1, Motoi Kuwahara1, Rino Ueno1, Makoto Samukawa1, Yukihiro Hamada1, Susumu Kusunoki2.
Abstract
We performed a serological investigation using glycoarray in Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and multifocal motor neuropathy (MMN). Antibodies to 10 glycolipids and 45 glycolipid complexes were tested. Anti-GM1/sulfatide and anti-GA1/sulfatide IgG antibodies were common in GBS (20.0% and 19.0%, respectively). Anti-GQ1b/sulfatide IgG antibody was detected in 14.0% of GBS patients. IgG antibodies to antigens containing GQ1b were significantly correlated with ophthalmoplegia in GBS (p<0.01). IgM antibodies to antigens containing GM1 or GalNAc-GD1a were in 50% and 37.5% of MMN patients, respectively. Glycoarray is efficient for detecting antibodies against numerous glycolipid complexes in immune-mediated neuropathies. Copyright ÂEntities:
Keywords: Antibodies; Glycoarray; Glycolipid complex; Guillain-Barré syndrome; Multifocal motor neuropathy
Mesh:
Substances:
Year: 2016 PMID: 27836184 DOI: 10.1016/j.jneuroim.2016.10.010
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478